Cannabis Education
Medical Cannabis Strains: An Evidence-Based Guide for Australians
Aug
The term medical cannabis strains is commonly used to describe cannabis cultivars that are associated with medicinal cannabis products. However, modern healthcare and scientific research increasingly focus on a product’s cannabinoid profile—such as its levels of cannabidiol (CBD) and tetrahydrocannabinol (THC)—rather than relying on strain names alone.
In Australia, medicinal cannabis products are regulated under a national therapeutic framework. Healthcare professionals prescribe regulated cannabinoid medicines based on clinical evidence, product quality, and an individual’s medical needs, rather than selecting products solely because they are labelled as a particular strain.
This educational guide explains what medical cannabis strains are, how they are classified, how cannabinoids work, current areas of research, and Australia’s regulatory approach.
What Are Medical Cannabis Strains?
A cannabis strain, also known as a cultivar, refers to a cultivated variety of the cannabis plant with distinct genetic characteristics.
Historically, strains have often been described as:
- Cannabis sativa
- Cannabis indica
- Hybrid varieties
Modern scientific research has shown that these labels do not consistently predict the cannabinoid composition or therapeutic effects of a product.
Why Cannabinoid Profiles Matter
Healthcare professionals generally place greater importance on the chemical composition of a medicinal cannabis product than its strain name.
The most researched cannabinoids include:
- Cannabidiol (CBD) – generally considered non-intoxicating.
- Tetrahydrocannabinol (THC) – the primary psychoactive cannabinoid.
Laboratory testing allows medicinal products to be described by their cannabinoid content, providing more reliable information than a strain name alone.
How Cannabinoids Work
Cannabinoids interact with the body’s endocannabinoid system (ECS).
The ECS helps regulate numerous physiological processes, including:
- Pain perception
- Mood
- Sleep
- Appetite
- Memory
- Stress responses
- Immune function
Different cannabinoids interact with this system in different ways, contributing to their differing pharmacological effects.
Common Cannabinoid Profiles
Rather than focusing on strain names, regulated medicinal cannabis products are commonly described by their cannabinoid composition.
| Cannabinoid Profile | General Characteristics |
|---|---|
| CBD-Dominant | Higher cannabidiol content with little or no THC, depending on the formulation |
| Balanced CBD | Contains both cannabinoids in defined proportions |
| THC-Dominant | Higher tetrahydrocannabinol content |
Conditions Being Studied
Researchers continue investigating regulated cannabinoid medicines for selected medical conditions.
Chronic Pain
Some evidence suggests selected cannabinoid medicines may help certain patients with chronic pain, particularly neuropathic pain.
Treatment-Resistant Epilepsy
Prescription CBD medicines have demonstrated benefits for some rare forms of treatment-resistant epilepsy.
This remains one of the strongest areas of evidence supporting cannabinoid therapy.
Chemotherapy-Induced Nausea and Vomiting
THC-containing medicines have been studied for managing nausea and vomiting associated with chemotherapy in selected patients.
Multiple Sclerosis-Related Spasticity
Research suggests certain cannabinoid medicines may help reduce muscle stiffness and spasms in people with multiple sclerosis.
Palliative Care
Cannabinoids continue to be investigated for symptom management in palliative care, including:
- Pain
- Appetite changes
- Sleep disturbance
- Nausea
Why Strain Names Alone Are Not Reliable
Products marketed under the same strain name may differ because of variations in:
- Plant genetics
- Growing conditions
- Harvest timing
- Processing methods
- Manufacturing standards
For this reason, modern clinical practice relies more heavily on laboratory-tested cannabinoid profiles.
Possible Side Effects
Like all medicines, cannabinoid products may cause side effects.
Reported side effects include:
- Drowsiness
- Fatigue
- Dry mouth
- Dizziness
- Appetite changes
- Reduced concentration
Products containing THC may also temporarily impair coordination, judgement, and reaction time.
Australian Regulation
Medicinal cannabis products are regulated in Australia through the Therapeutic Goods Administration (TGA) together with Commonwealth, state, and territory medicines legislation.
Healthcare professionals consider:
- Medical history
- Previous treatments
- Current medicines
- Available scientific evidence
- Potential benefits
- Potential risks
before determining whether a medicinal cannabis product is clinically appropriate.
Educational Comparison Table
| Topic | Traditional Strain Names | Modern Medical Classification |
| Primary Focus | Plant variety | Cannabinoid profile |
| Clinical Importance | Limited | High |
| Product Description | Marketing or botanical terminology | Laboratory-tested cannabinoid composition |
| Healthcare Use | Secondary | Primary consideration |
Ongoing Scientific Research
Scientists continue investigating cannabinoids for potential roles in:
- Chronic pain
- Neurological disorders
- Treatment-resistant epilepsy
- Anxiety disorders
- Inflammatory diseases
- Cancer symptom management
- Neurodegenerative disorders
While evidence supports certain therapeutic uses, many potential applications remain under active investigation.
Where to Learn More
Reliable educational information is available at https://aussiemedicalcannabis.com/
- Therapeutic Goods Administration – Medicinal Cannabis
- Australian Government Department of Health, Disability and Ageing – Medicinal Cannabis
- Healthdirect Australia
PubMed Reference
Frequently Asked Questions
1. What are medical cannabis strains?
Medical cannabis strains are cultivated varieties of cannabis associated with medicinal cannabis products. In modern healthcare, clinicians generally focus on cannabinoid content rather than strain names.
2. Are strain names important in medicine?
Strain names alone are not reliable indicators of therapeutic effects. Laboratory-tested cannabinoid profiles provide more meaningful clinical information.
3. What are the main cannabinoids?
The two most researched cannabinoids are cannabidiol (CBD), which is generally non-intoxicating, and tetrahydrocannabinol (THC), which is psychoactive.
4. What conditions have medicinal cannabinoids been studied for?
Research has investigated cannabinoid medicines for chronic pain, treatment-resistant epilepsy, chemotherapy-induced nausea and vomiting, multiple sclerosis-related spasticity, and selected symptoms in palliative care.
5. Are medicinal cannabis products regulated in Australia?
Yes. Medicinal cannabis products are regulated under Australia’s therapeutic goods and medicines framework.
Conclusion
Although the phrase “medical cannabis strains” remains widely used, contemporary medicine focuses primarily on cannabinoid composition, product quality, and scientific evidence rather than traditional strain names. Australia’s regulated medicinal cannabis framework supports evidence-based prescribing, quality assurance, and patient safety while research continues to expand our understanding of cannabinoid medicines.
